GlassScriptPhysician profile
Kerri Jo Neff
NPI 1013969302
$3,907.98
in general payments reported to CMS, 2019-2025
28 companies · $795 in 2025
The $795 reported for 2025 was more than what 93% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $587 · 2022: $944 · 2023: $1,345 · 2024: $238 · 2025: $795.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,277 · Education: $99.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,277.46 |
| Education | $99.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $650.53 | 2021-2025 | Slynd, Twirla |
| Mayne Pharma Commercial LLC | $513.06 | 2021-2025 | |
| Abbvie INC. | $412.14 | 2021-2023 | |
| Novo Nordisk INC | $291.49 | 2022-2023 | Wegovy |
| Astellas Pharma US INC | $249.74 | 2023-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $207.89 | 2021-2024 | |
| Hologic Sales and Service, LLC | $202.64 | 2022-2024 | Aptima |
| Sage Therapeutics, LLC | $190.23 | 2023-2025 | Zurzuvae |
| Agile Therapeutics, INC. | $174.43 | 2021-2022 | |
| Stryker Corporation | $173.97 | 2025 | Clottriever Bold Catheter |
| Aspira Women'S Health INC | $134.38 | 2023 | Ova1 |
| Bayer Healthcare Pharmaceuticals INC. | $121.40 | 2021-2025 | |
| Mylan Pharmaceuticals INC. | $80.77 | 2021-2022 | |
| Shield Therapeutics INC | $76.27 | 2023-2025 | Accrufer |
| Gynesonics, INC. | $58.91 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $58.45 | 2023-2025 | Myfembree |
| Avion Pharmaceuticals | $47.43 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $35.04 | 2021 | |
| Myovant Sciences INC. | $34.71 | 2021-2022 | |
| Lilly USA, LLC | $33.18 | 2025 | Zepbound |
| Therapeuticsmd, INC. | $31.12 | 2021-2022 | |
| Organon LLC | $29.77 | 2024 | |
| Daiichi Sankyo INC. | $21.64 | 2024 | Injectafer |
| Ethicon US, LLC | $17.26 | 2024 | Ethicon, Enseal X1 |
| Supernus Pharmaceuticals, INC. | $16.37 | 2025 | Qelbree |
| Millicent US INC | $15.62 | 2025 | Intrarosa |
| Exact Sciences Corporation | $14.92 | 2025 | The Cologuard Plus Collection Kit |
| Davol INC. | $14.62 | 2023 | Arista Ah Flexitip |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kerri Neff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.